Details for New Drug Application (NDA): 050081
✉ Email this page to a colleague
NDA 050081 describes POLY-PRED, which is a drug marketed by Allergan and is included in one NDA. Additional details are available on the POLY-PRED profile page.
The generic ingredient in POLY-PRED is neomycin sulfate; polymyxin b sulfate; prednisolone acetate. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; polymyxin b sulfate; prednisolone acetate profile page.
The generic ingredient in POLY-PRED is neomycin sulfate; polymyxin b sulfate; prednisolone acetate. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; polymyxin b sulfate; prednisolone acetate profile page.
Summary for 050081
| Tradename: | POLY-PRED |
| Applicant: | Allergan |
| Ingredient: | neomycin sulfate; polymyxin b sulfate; prednisolone acetate |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION/DROPS;OPHTHALMIC | Strength | EQ 0.35% BASE;10,000 UNITS/ML;0.5% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
